How to Navigate Generative AI Regulation in Health Care
Wednesday, 4 September 2024, 07:43
Understanding the Challenges of AI Regulation in Health Care
Regulating generative AI in health care is becoming increasingly critical. The traditional approaches utilized by the FDA for new drugs and devices fall short when faced with the unique characteristics of generative AI technologies.
Innovative Strategies for AI Oversight
- Collaboration with Tech Experts
- Establishing Clear Guidelines
- Monitoring AI Performance
Policymakers are urged to work closely with technology experts to draft regulations that can effectively manage the risks associated with generative AI in health domains.
The Role of Global Regulators
- Define Standards
- Ensure Compliance
- Promote Transparency
Global regulatory bodies need to redefine their roles to adequately oversee the dynamic nature of AI innovations.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.